Business
Currency:USD
2024/Q1
Stock NameRevenueRatio
BioPharma14.6B98.15%
Other business activities275M1.85%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States27.09B46.31%
Emerging Markets12B20.51%
Developed Europe11.65B19.92%
Developed Rest of World4.25B7.27%
Japan3.51B6.00%